The epidemiology and control of Acinetobacter baumannii in health care facilities.

By P. Fournier, H. Richet. Clinical Infectious Diseases, 2006

962 citations recorded by the source corpus.

Subfields: Endocrinology, Epidemiology, Molecular Medicine

View Paper: https://www.semanticscholar.org/paper/e140125b78873d52812df903bc71bde7174b3bc3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology

In Epidemiology

In Molecular Medicine

Citations in the corpus

Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 (2024, positive): “We excluded combinations of antibiotics to which bacteria have intrinsic resistance (appendix 1 pp 51–55).”
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges (2016, background): “baumannii remained viable in hospital units after months— even years— on a solid surface, underscoring the challenge to eliminating environmental transmission of the organism once it has colonized nosocomial surfaces (97, 98).”
Acinetobacter baumannii: Emergence of a Successful Pathogen (2008, methodology): “Other ESBLs identified in A. baumannii include TEM-92 and -116 (148, 387), from Italy and The Netherlands, respectively, and SHV-12 from China and The Netherlands (248, 387).”
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. (2008, background): “Other studies that rigorously controlled for severity of illness did not find Acinetobacter infection to be independently associated with increased mortality [1, 49, 55, 56].”
Global Challenge of Multidrug-Resistant Acinetobacter baumannii (2007, background): “baumannii also causes, albeit less frequently, complicated skin and soft tissue, abdominal, and central nervous system infections (46).”
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options (2017, background): “Most A. baumannii infections occur in critically ill patients in the intensive care unit (ICU) setting (Fournier and Richet, 2006) and account for up to 20% of infections in ICUs worldwide (Vincent et al., 2009).”
Acinetobacter baumannii (2012, neutral): “baumannii is also ubiquitous.(26) While not all Acinetobacters find their habitat in the natural environment, a thorough and systematic study to investigate the natural occurrence of the various Acinetobacter species in the environment has yet to be performed.”
Hospital Epidemiology and Infection Control in Acute-Care Settings (2011, background): “Traditionally, these outbreaks are associated with ICUs, respiratory equipment, or water sources and have been difficult to contain because of the associated environmental contamination (101, 199, 331).”